MARCHIONI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 1.959
AS - Asia 1.158
EU - Europa 852
Continente sconosciuto - Info sul continente non disponibili 195
SA - Sud America 194
AF - Africa 42
OC - Oceania 3
Totale 4.403
Nazione #
US - Stati Uniti d'America 1.805
IT - Italia 758
BD - Bangladesh 420
CN - Cina 248
SG - Singapore 229
BR - Brasile 118
HK - Hong Kong 79
CA - Canada 62
IN - India 34
VN - Vietnam 32
MX - Messico 25
AR - Argentina 24
GB - Regno Unito 20
SA - Arabia Saudita 18
CR - Costa Rica 16
ID - Indonesia 15
CO - Colombia 14
TR - Turchia 14
JM - Giamaica 11
PE - Perù 11
ES - Italia 10
IQ - Iraq 10
DE - Germania 9
EC - Ecuador 9
CL - Cile 8
GT - Guatemala 8
NL - Olanda 8
PH - Filippine 8
PK - Pakistan 8
FR - Francia 7
TH - Thailandia 7
DZ - Algeria 6
HN - Honduras 6
LT - Lituania 6
VE - Venezuela 6
ZA - Sudafrica 6
BB - Barbados 5
KZ - Kazakistan 5
MA - Marocco 5
SV - El Salvador 5
EG - Egitto 4
IE - Irlanda 4
KE - Kenya 4
MY - Malesia 4
PL - Polonia 4
RU - Federazione Russa 4
SC - Seychelles 4
TN - Tunisia 4
UA - Ucraina 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
NI - Nicaragua 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AL - Albania 2
AW - Aruba 2
AZ - Azerbaigian 2
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IL - Israele 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
ET - Etiopia 1
FI - Finlandia 1
GA - Gabon 1
GH - Ghana 1
GN - Guinea 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
ML - Mali 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MV - Maldive 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
TG - Togo 1
UY - Uruguay 1
Totale 4.208
Città #
San Jose 650
Ashburn 348
Council Bluffs 191
Beijing 136
Milan 117
Santa Clara 97
Singapore 89
Hong Kong 78
Rome 76
New York 59
Figino 45
Naples 41
Los Angeles 40
Buffalo 24
Turin 23
Bologna 20
Genoa 19
Catania 15
Mexico City 15
Bari 14
Palermo 14
Ho Chi Minh City 13
San José 12
Toronto 12
Dallas 10
Florence 10
Lima 10
Verona 10
Hanoi 9
São Paulo 9
Montreal 8
Padua 8
Atlanta 7
Kingston 7
Phoenix 7
Riyadh 7
Chicago 6
Seattle 6
Brescia 5
Guatemala City 5
Las Vegas 5
London 5
Miami 5
Recife 5
Taranto 5
Yalova 5
Chandigarh 4
Guayaquil 4
Jeddah 4
Lancaster 4
Medellín 4
Medina 4
Mumbai 4
Quito 4
Rio de Janeiro 4
San Salvador 4
Tashkent 4
Venice 4
Winnipeg 4
Algiers 3
Athens 3
Baghdad 3
Barquisimeto 3
Brasília 3
Bridgetown 3
Cagliari 3
Charlotte 3
Davao City 3
Denver 3
Edmonton 3
Frankfurt am Main 3
Jackson 3
Lissone 3
Managua 3
Modena 3
Monza 3
Nairobi 3
Newark 3
Niagara Falls 3
Orlando 3
Pasadena 3
Pescara 3
Philadelphia 3
Ravenna 3
Richmond 3
San Francisco 3
San Pedro Sula 3
Tampa 3
Warsaw 3
Afragola 2
Agadir 2
Alajuela 2
Albuquerque 2
Andria 2
Avellino 2
Baku 2
Bogotá 2
Borgosesia 2
Boston 2
Brooklyn 2
Totale 2.466
Nome #
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 440
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy 82
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy 78
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 68
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis 65
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 55
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 53
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC) 53
Enzalutamide in patients with castration-refractory prostate cancer: Retrospective, multicenter, real life study 44
Multiple chromophobe and clear cell renal cancer in a patient affected by Birt-Hogg-Dubè syndrome: a case report 43
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 40
Neoadjuvant chemotherapy before radical cystectomy: Why we must adhere? 38
Major acute cardiovascular events after transurethral prostate surgery: a population-based analysis 37
Cholinergic Markers and Cytokines in OSA Patients 37
Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis 37
North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients 36
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 35
Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review 33
Management of de-novo graft masses in kidney transplantation recipients: focusing on available data and unmet clinical needs 33
Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study 32
Neobladder "Function": Tips and Tricks for Surgery and Postoperative Management 32
Comprehensive analysis of in-hospital delirium after major surgical oncology procedures 31
New Anti-Androgen Compounds Compared to Docetaxel in Metastatic Hormone Sensitive Prostate Cancer: Results from a Network Meta-Analysis 31
Effects of Curcumin and Lactoferrin to Inhibit the Growth and Migration of Prostatic Cancer Cells 31
A drug safety evaluation of abiraterone acetate in the treatment of prostate cancer 30
Current management of radiation cystitis after pelvic radiotherapy: a systematic review 30
Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Systematic Review and Quantitative Synthesis by the European Association of Urology Young Academic Urologists Renal Cancer Study Group 30
Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging 29
Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ‘real-life’ studies 29
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma 29
Efficacy and safety of intravesical fibrin glue instillation for management of patients with refractory hemorrhagic cystitis: 12-months results. A promising therapy for hemorrhagic cystitis 28
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature 28
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group) 27
Radiomics in prostate cancer: an up-to-date review 27
Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma 27
The safety and feasibility of the simultaneous use of 180-W GreenLight laser for prostate vaporization during concomitant surgery 27
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 27
Abiraterone acetate for early stage metastatic prostate cancer: Patient selection and special considerations 26
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study 26
Nutrigenetic variants and response to diet/lifestyle intervention in obese subjects: a pilot study 26
Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach 26
Correlation between Choriocapillaris Density and Retinal Sensitivity in Stargardt Disease 26
Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy 26
Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis 26
Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy 25
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) 25
Fat mass and obesity-associated (FTO) gene epigenetic modifications in gestational diabetes: new insights and possible pathophysiological connections 25
Retroperitoneal extension of massive ulcerated testicular seminoma through the inguinal canal: A case report 25
Leydig cell tumor in a 53-year-old patient with gynecomastia and gynecodynia: A case report and literature review 24
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals 24
Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: A literature review 24
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis 24
RIRS in the elderly: Is it feasible and safe? 24
Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study 23
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 23
PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers 23
Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma 23
Lower Bladder Toxicity of Salvage Versus Adjuvant Modern Radiotherapy for Prostate Cancer Patients 23
Surgical and oncological management of renal medullary carcinoma in a young patient: a case report 23
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 22
Mastering bladder paraganglioma for optimal treatment: a case report of robot-assisted surgery 22
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 22
GreenLight Photoselective Vaporization of the Prostate: One Laser for Different Prostate Sizes 22
Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review 22
Transurethral prostate surgery in prostate cancer patients: A population-based comparative analysis of complication and mortality rates 22
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer 22
Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era 21
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 21
Bladder Neck Contracture After Endoscopic Surgery for Benign Prostatic Obstruction: Incidence, Treatment, and Outcomes 21
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study 21
Urology Residency Training in Italy: Results of the First National Survey 21
Management of local recurrence after radical nephrectomy: surgical removal with or without systemic treatment is still the gold standard. Results from a multicenter international cohort 21
Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies: Phase IIa Clinical Study 21
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium 21
Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages 21
Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors 21
Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies 21
The Surgical Experience Influences the Safety and Efficacy of Photovaporization of Prostate with 180-W XPS GreenLight Laser: Comparison Between Novices vs Expert Surgeons Learning Curves 20
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 20
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 20
Infective complications after retrograde intrarenal surgery: a new standardized classification system 20
The effect of institution teaching status on perioperative outcomes after robotic partial or radical nephrectomy 20
Persistence and adherence to androgen deprivation therapy in men with prostate cancer: an administrative database study 20
Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses 20
The Impact of Ureteroscopy following Computerized Tomography Urography in the Management of Upper Tract Urothelial Carcinoma COMMENT 20
The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review 20
MP08-03 PROGRESSION-FREE SURVIVAL AS SURROGATE ENDPOINT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER STUDIES: RESULTS FROM A MACHINE LEARNING-BASED ANALYSIS OF A LARGE MULTI-INSTITUTIONAL DATABASE 20
Inferior vena cava involvement in renal cell carcinoma: if you fail to plan, you’re planning to fail 19
Robotic partial nephrectomy in 3D virtual reconstructions era: is the paradigm changed? 19
Predictors of re-intervention after greenlight laser photoselective vaporization of the prostate: multicenter long/mid-term follow-up experience 19
Chatgpt vs traditional pedagogy: a comparative study in urological learning 19
Detection Rate of Prostate-Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis 19
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 19
Trifecta and pentafecta rates after robotic assisted partial nephrectomy: Comparative study of patients with renal masses <4 and ≥4 cm 19
High Neutrophil-to-lymphocyte Ratio as Prognostic Factor in Patients Affected by Upper Tract Urothelial Cancer: A Systematic Review and Meta-analysis 19
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis 19
Monocenter Experience with 532 Nm-Laser Photoselective-Vaporization of the Prostate by GreenLight XPS Laser: Is It Really an Endourological Joker Card? 19
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 19
Estimating Postoperative Renal Function After Surgery for Nonmetastatic Renal Masses: A Systematic Review of Available Prediction Models 19
A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma 18
Totale 3.203
Categoria #
all - tutte 17.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202518 0 0 0 1 3 1 2 3 1 1 3 3
2025/20262.690 4 0 4 99 59 32 252 198 921 215 587 319
2026/20271.695 140 511 510 534 0 0 0 0 0 0 0 0
Totale 4.403